What are the impacts of chronic subclinic inflammation in patients with rheumatic mitral stenosis?

International Journal of Cardiology

Volumn 117, Issue 1, 2007, Pages 140-

  Turhan, Hasan ^a   Yetkin, Ertan ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Inflammation; Mitral regurgitation; Mitral stenosis; Valvuloplasty

Indexed keywords

ANTIINFLAMMATORY AGENT;

ARTICLE; CARDIAC PATIENT; CHRONIC INFLAMMATION; DISEASE COURSE; DISEASE MARKER; FOLLOW UP; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC HEART DISEASE; SENSITIVITY ANALYSIS;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; MITRAL VALVE STENOSIS; RHEUMATIC HEART DISEASE;

EID: 33947189513     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.05.038     Document Type: Article

References (4)

1. Harikrishnan S., Rajeev E., Tharakan J.A., et al. Acute phase reactants predict mitral regurgitation following mitral valvuloplasty. Int J Cardiol (Dec 12 2005) [Electronic publication ahead of print]
2. Yetkin E., Erbay A.R., Ileri M., et al. Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 88 (2001) 1209-1211
3. Golbasi Z., Ucar O., Keles T., et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 4 (2002) 593-595
4. Chiu-Braga Y.Y., Hayashi S.Y., Schafranski M., and Messias-Reason I.J. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Int J Cardiol 109 (2006) 275-276